Rapid boosting of HIV-1 neutralizing antibody responses in humans following a prolonged immunologic rest period

Academic Article

Abstract

  • © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. Background. The durability and breadth of human immunodeficiency virus type 1 (HIV-1)-specific immune responses elicited through vaccination are important considerations in the development of an effective HIV-1 vaccine. Responses to HIV-1 envelope subunit protein (Env) immunization in humans are often described as short-lived. Methods. We enrolled 16 healthy volunteers who had received priming with an HIV-1 subtype B Env vaccine given with MF59 adjuvant 5-17 years previously and 20 healthy unprimed volunteers. Three booster immunizations with a heterologous subtype C trimeric gp140 protein vaccine were administered to the primed group, and the same subtype C gp140 protein vaccination regimen was administered to the unprimed subjects. Results. Binding antibodies and neutralizing antibodies to tier 1 viral isolates were detected in the majority of previously primed subjects. Remarkably, a single dose of protein boosted binding and neutralizing antibody titers in 100% of primed subjects following this prolonged immunologic rest period, and CD4+ T-cell responses were boosted in 75% of primed individuals. Conclusions. These results demonstrate that HIV-1 protein immunogens can elicit durable memory T- and B-cell responses and that strong tier 1 virus neutralizing responses can be elicited by a single booster dose of protein following a long immunologic rest period. However, we found no evidence that cross-clade boosting led to a significantly broadened neutralizing antibody response.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Spearman P; Tomaras GD; Montefiori DC; Huang Y; Elizaga ML; Ferrari G; Munir Alam S; Isaacs A; Ahmed H; Hural J
  • Start Page

  • 1755
  • End Page

  • 1765
  • Volume

  • 219
  • Issue

  • 11